Literature DB >> 25459243

Association of cognitive impairment and lesion volumes in multiple sclerosis--a MRI study.

Murat Yildiz1, Barbara Tettenborn2, Ernst-Wilhelm Radue3, Kerstin Bendfeldt3, Stefan Borgwardt4.   

Abstract

UNLABELLED: Cognitive impairment (CI) can be demonstrated in 40-65% of multiple sclerosis (MS) patients, sometimes starting from the early stages of the disease. The objective of this study was a community-based investigation of FLAIR-hyperintense lesion volumes (LV) and their association with CI in patients with relapsing remitting (RR) MS. The neurocognitive assessment was conducted with the brief cognitive screening instrument, MUSIC. Magnetic resonance imaging (MRI) scans were obtained with a 1.5 Tesla Sigma Magnetom MRI scanner. We conducted a stepwise multiple regression analysis to assess the relative contribution of the main clinical, demographic and MRI-variables in predicting cognitive impairment. We recruited 78 patients with RRMS. The mean MUSIC score was 20.6 ± 5.4. Forty five percent of patients (n = 35, mean score 15.1 ± 3.3) had CI and 55% (n = 43, mean score 24.4 ± 2.5) had no sign of CI. In the correlation analysis of the MUSIC subtests only the interference test correlated negatively with the LV (r = -0.23). Multivariate linear regression analysis using MUSIC as the dependent continuous variable revealed LV and disability severity as independent factors associated with MUSIC (p value of the regression model < 0.001; adjusted R-square = 0.11). The results of the present study suggest an association between white matter damage and CI in MS. We could demonstrate an association between attention difficulties and the LV in MS patients. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01250665 and NCT01250678.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognitive impairment; Lesion volume; MRI; Multiple sclerosis

Mesh:

Year:  2014        PMID: 25459243     DOI: 10.1016/j.clineuro.2014.09.019

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  8 in total

1.  Balance in multiple sclerosis: relationship to central brain regions.

Authors:  Richard L Doty; Michael R MacGillivray; Hussam Talab; Isabelle Tourbier; Megan Reish; Sherrie Davis; Jennifer L Cuzzocreo; Neil T Shepard; Dzung L Pham
Journal:  Exp Brain Res       Date:  2018-07-17       Impact factor: 1.972

2.  Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity.

Authors:  A Beer; V Biberacher; P Schmidt; R Righart; D Buck; A Berthele; J Kirschke; C Zimmer; B Hemmer; M Mühlau
Journal:  J Neurol       Date:  2016-05-13       Impact factor: 4.849

3.  Taste dysfunction in multiple sclerosis.

Authors:  Richard L Doty; Isabelle A Tourbier; Dzung L Pham; Jennifer L Cuzzocreo; Jayaram K Udupa; Bilge Karacali; Evan Beals; Laura Fabius; Fidias E Leon-Sarmiento; Gul Moonis; Taehoon Kim; Toru Mihama; Rena J Geckle; David M Yousem
Journal:  J Neurol       Date:  2016-01-25       Impact factor: 4.849

4.  Cortical pathology in multiple sclerosis detected by the T1/T2-weighted ratio from routine magnetic resonance imaging.

Authors:  Ruthger Righart; Viola Biberacher; Laura E Jonkman; Roel Klaver; Paul Schmidt; Dorothea Buck; Achim Berthele; Jan S Kirschke; Claus Zimmer; Bernhard Hemmer; Jeroen J G Geurts; Mark Mühlau
Journal:  Ann Neurol       Date:  2017-09-16       Impact factor: 10.422

Review 5.  The clinico-radiological paradox of cognitive function and MRI burden of white matter lesions in people with multiple sclerosis: A systematic review and meta-analysis.

Authors:  Daisy Mollison; Robin Sellar; Mark Bastin; Denis Mollison; Siddharthan Chandran; Joanna Wardlaw; Peter Connick
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

Review 6.  Symptom Interconnectivity in Multiple Sclerosis: A Narrative Review of Potential Underlying Biological Disease Processes.

Authors:  Tanuja Chitnis; Jo Vandercappellen; Miriam King; Giampaolo Brichetto
Journal:  Neurol Ther       Date:  2022-06-09

7.  Correlation of MRI findings and cognitive function in multiple sclerosis patients using montreal cognitive assessment test.

Authors:  Farzad Ashrafi; Behdad Behnam; Mehran Arab Ahmadi; Morteza Sanei Taheri; Hamid Reza Haghighatkhah; Hossein Pakdaman; Seyed Mohammad Hadi Kharrazi
Journal:  Med J Islam Repub Iran       Date:  2016-04-17

8.  Impact of disease-modifying therapies on MRI and neurocognitive outcomes in relapsing-remitting multiple sclerosis: a protocol for a systematic review and network meta-analysis.

Authors:  Samuel Lees; Mathew Dicker; Jie En Ku; Varun Chaganti; Matthew Mew-Sum; Nick Wang; Angela Smith; Christopher Oldmeadow; Wooi Lynn Goon; Marc Bevan; Danielle Lang; Madeleine Hinwood
Journal:  BMJ Open       Date:  2021-11-02       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.